HCV Product PIs | GileadPro

UK Prescribing Information for Sofosbuvir/Velpatasvir Gilead¹

UK Prescribing Information for Ledipasvir/Sofosbuvir Gilead²

UK Prescribing Information for Sofosbuvir/Velpatasvir/Voxilaprevir Gilead³

Stay up to date

Receive email updates from Gilead, including promotional communications.

References

1. UK Sofosbuvir/Velpatasvir Gilead Summary of Product Characteristics. https://www.emcpi.com/pi/32177 Accessed October 2025.
2. UK Ledipasvir/Sofosbuvir Gilead Summary of Product Characteristics. https://www.emcpi.com/pi/38293 Accessed October 2025.
3. UK Sofosbuvir/Velpatasvir/Voxilaprevir Gilead Summary of Product Characteristics. https://www.emcpi.com/pi/33858 Accessed October 2025.

UKI-EPC-0078 | October 2025

Adverse events should be reported.

For the UK, reporting forms and information can be found at www.mhra.gov.uk/yellowcard or via the Yellow Card app (download from the Apple App Store or Google Play Store). For IE, reporting forms and information can be found at www.hpra.ie and can be reported to HPRA on +353 1 6764971. Adverse events should also be reported to Gilead to [email protected] or +44(0) 1223 897500 or +353(0) 21 482 5999.